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Abstract
Background: Balloon valvuloplasty was established as an alternative to surgery for treatment of aortic valve stenosis in childhood. 
Acute complications after balloon dilatation including aortic insufficiency or early death were described.
Aim of Work: To analyze early outcome and midterm results of balloon aortic valvuloplasty (BAV) in Children’s Hospital, Mansoura 
University, Egypt.
Subjects and Methods: Between April 2005–June 2008, all consecutive patients of age ,18 years treated for aortic valve stenosis 
(AVS) with BAV were analyzed retrospectively. The study included 21 patients; 17 males, and 4 females. Their age ranged from the 
neonatal period to 10 years (mean age 5.6 ± 3.7 years). Patients with gradient $50 mmHg and aortic valve insufficiency (AI) up to grade 
I were included. All patients had isolated aortic valve stenosis except 3 patients (14.3%) had associated aortic coarctation. Six patients 
(28.6%) had bicuspid aortic valve. All patients had normal myocardial function except one (4.8%) had FS 15%. The duration of follow 
up was (mean ± SD: 18.5 ± 11.7 months).
Results: Femoral artery approach was used in 20 patients (95.2%) and carotid artery in one neonate (4.8%). Balloon/annulus ratio was 
0.83 ± 0.04. Significant reduction in pressure gradient was achieved (mean 66.7 ± 9.8 mmHg to 20.65 ± 2.99 mmHg) (P , 0.001). 
Nine patients (42.8%) developed grade I AI, 2 patients (9.5%) developed grade II AI and 1 patient (4.8%) developed grade III AI. 
Two early deaths (9.5%); one died due to heart failure caused by grade IV AI and a neonate died because of severely compromised LV 
  function. One patient (4.8%) had femoral artery occlusion necessitating anticoagulation. Patients remained free from re-intervention 
during   follow up.
Conclusion:  Balloon  valvuloplasty  of  aortic  valve  stenosis  significantly  reduces  gradient  with  low  morbidity  and  mortality  in 
children.
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Introduction
Aortic  valve  stenosis  (AVS)  represents  3%–7%  of 
all congenital heart diseases.1 There is consensus in 
the management of mild and severe forms of AVS 
but there is a tendency for balloon aortic valvulo-
plasty  (BAV)  except  in  the  presence  of  dysplastic 
aortic valve or associated moderate to severe aortic 
    insufficiency.2 So, BAV has been established as an 
alternative to surgery for therapy of AVS in child-
hood3,4 and has proven to be an effective method for 
decreasing gradient between the left ventricle and the 
aorta.5,6 BAV in congenital AVS provides palliation 
that is comparable to that achieved by surgical aor-
tic valvotomy, but without the risks and morbidity of 
surgery.6,7 Acute complications after BAV leading to 
early death (,30 days) have been described8 as well as 
the development of aortic insufficiency as a long term 
complication during follow up.9,10 The clinical status, 
aortic valve morphology, myocardial function at time 
of intervention and age of the patient are possible risk 
factors determining the outcome of BAV.11,12
The aim of this study was to analyze the early and 
intermediate term follow up results of BAV of AVS 
in childhood and to present our own experience in 
this issue.
Material and Methods
Patients
All consecutive patients younger than 18 years who 
underwent  BAV  for  congenital AVS  in  Children’s 
  Hospital,  Mansoura  University,  Egypt  were  ana-
lyzed retrospectively in the period from April 2005 to 
June 2008 as regarding their demographic, clinical, 
echocardiographic, hemodynamic and angiographic 
data.   Written informed consent was obtained from 
all   parents of the children included in the study. The 
Institutional Ethical Review Board of the Children’s 
Hospital had approved the study.
All patients had isolated congenital AVS except 
3  patients  who  had  associated  discrete  juxtaductal 
aortic coarctation (COA). Patients were subjected to 
clinical examination including symptoms as dyspnea 
and signs of congestive heart failure or ductal depen-
dency in neonates. Echocardiography was performed 
to  all  patients  by  expert  pediatric  cardiologists, 
using  the  SONOS-5500  device  (Hewlett-Packard, 
Andover, MA) and an 8-MHz probe, and their data 
were  analyzed  as  regard  aortic  valve  morphology, 
left   ventricular (LV) function, transvalvular gradient 
(peak and mean), annulus diameter, grade of aortic 
insufficiency (AI) (if any) and associated anomalies. 
Aortic  valve  morphology  was  determined  from  a 
parasternal short-axis view and classified as tricuspid 
and bicuspid. A semi-quantitative estimate of severity 
of AI was made by using color-flow and pulsed-wave 
Doppler  echocardiography.  The  degree  of AI  was 
graded and defined as none, trivial, mild, moderate, 
or severe (or 0-IV).13–15
Continuous Wave Doppler (CWD) tracing to the 
aortic valve was done to measure the peak instan-
taneous  gradient  through  the  valve  by  measuring 
the maximal systolic velocity from either apical or 
suprasternal view and calculating a pressure gradi-
ent using the modified Bernoulli equation (pressure 
gradient = 4 × [maximal velocity]2) and time velocity 
integral of Doppler curve to calculate the mean pres-
sure  gradient.  Echocardiographic  examination  was 
done at time of diagnosis, one day after intervention, 
and repeatedly during follow up.
Patients  with  a  Doppler  peak  instantaneous 
  gradient $ 50 mmHg, and those with associated mild 
aortic insufficiency (AI) were included in the study. 
Patients with moderate to severe AI, associated con-
genital heart disease need surgical intervention, or 
those  with  associated  supravalvular  stenosis  were 
excluded. The outcome was either successful BAV, 
failure or reintervention either by further balloon or 
by surgery and procedure related complications as 
rhythm  disturbances,  aortic  valve  insufficiency  by 
different grades, vascular complications, recurrence 
during  follow  up  necessitating    re-intervention  or 
death.
BAV Technique
BAV  was  indicated  when  peak  instantaneous  pres-
sure gradient across the valve $50 mmHg in patients 
with normal myocardial systolic function (FS $ 28%) 
and with lower peak instantaneous pressure gradient 
in patients with an impaired myocardial systolic func-
tion (FS , 28%). BAV was performed under general 
anesthesia using Sephoflourane and under biplane flu-
oroscopic guidance. Heparin was administered during 
the procedure in a dose of 100 IU/Kg. The catheteriza-
tion technique was performed through femoral artery 
access in all patients and retrograde aortic approach to 
the aortic valve as described by Mullins16 except one Balloon aortic valvuloplasty in childhood
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neonate where carotid artery approach was used. Left 
ventriculography was done and aortic valve annulus 
was measured during systole in 2 angiographic planes. 
An open-tip catheter was inserted and the peak-to- peak 
pressure gradient in the coarctation segment was esti-
mated in the three patients with associated coarctation. 
The catheter was advanced through the stenotic aortic 
valve into the left ventricle using soft tip guide-wire 
and the peak-to- peak pressure gradient across the aor-
tic valve was estimated. Tayshak-II® or mini-Tayshak® 
(NuMed Canada, Inc.) balloons for valvuloplasty were 
used and their sizes were selected according to the 
  aortic annulus diameter with balloon annulus ratio #1. 
The  appropriate  length  of  the  balloon  was  selected 
according to the size of the patient. The balloon was 
advanced over the guide-wire and inflated at the level 
of valve orifice. In the three patients with associated 
COA, the balloon was withdrawn and a different-sized 
balloon  was  introduced  and  inflated  at  the  coarcta-
tion segment. The size of the balloon was selected 
according to the narrowest native diameter by balloon/
annulus ratio not exceeding 1. Heart rate slowing was 
achieved  by  intravenous  bolus  adenosine  with  dose 
0.3 mg/kg. Intravenous adenosine was injected rapidly, 
followed by a saline flush; this often resulted in a short 
period of sinus bradycardia followed by   asystole. After 
dilatation, peak-to-peak pressure gradient was remea-
sured across the valve (and the coarctation segment 
in the three patients with associated COA) to evalu-
ate any residual gradient. Aortic root angiography was 
  performed to detect aortic insufficiency.
After  BAV,  a  satisfactory  result  was  defined  as 
a  reduction  of  the  peak-to-peak  pressure  gradient 
of at least 50% or a residual gradient of less than 
25 mmHg. If satisfactory reduction was not achieved, 
redilatation using larger balloon and using adenosine 
to repeat procedure by the same previous dose fol-
lowed by angiography after each change in balloon 
size to detect aortic valve insufficiency. No further 
intervention was performed in any case, if a moderate 
aortic valve insufficiency was detected in the follow-
ing angiography or reach balloon/annulus ratio 1.
Statistical methods
Data were expressed as mean ± SD. Student t-test 
was used to compare variables. Paired t-test was used 
to compare the same patient before and after BAV. 
Statistical significance was identified as P , 0.05. 
Pearson’s correlation coefficient was used to assess 
the relationship between balloon annulus ratio and 
the degree of aortic insufficiency post intervention. 
Analysis  was  done  using  SpSS  soft  ware  (version 
16.0; SpSS, Chicago, IL, USA).
results
21  patients  underwent  BAV  for  congenital  aortic 
valve  stenosis,  17  males  (81%),  4  females  (19%). 
Demographic data of all patients are summarized in 
(Table 1). Two patients (9.5%) were presented during 
neonatal period by poor interrupted feeding, 8 patients 
(38%) were presented during infancy by dyspnea and 
11 patients (52.5%) were presented by accidentally 
discovered murmur.
Echocardiographic data before intervention were 
as follows: 15 patients (71.5%) had tricuspid aortic 
valve, 6 patients (28.5%) had bicuspid aortic valve. 
Among those with bicuspid aortic valve, 3 patients 
(14.3%)  had  associated  discrete  juxtaductal  aor-
tic  coarctation.  All  patients  had  severe  AS;  peak 
instantaneous pressure gradient across the valve was 
77.95 ± 5.9 mmHg. Seventeen patients (81%) had no 
AI, 3 patients (14.3%) had grade I AI and 1 patient 
(4.8%) had grade II AI. All patients had normal myo-
cardial systolic function (FS . 28%) except one who 
had affected myocardial systolic function (FS 15%).
We  performed  balloon  angioplasty  to  the  three 
patients with associated aortic coarctation at the same 
time of BAV with satisfactory results (Table 2).
Immediate outcome
Table 3 shows early follow up results.   During catheter-
ization, we found significant   reduction in   peak-to-peak 
pressure gradient across the   aortic valve after BAV 
from  66.7  ±  9.8  mmHg  to  20.65  ±  2.99  mmHg 
Table 1. Demographic, baseline clinical data of the patients.
Demographic data
Age (years) (mean ± SD)  5.6 ± 3.7 years
  neonates (age # 28 days) (n, %) 2 (9.5%)
  Children (age . 28 days) (n, %) 18 (90.5%)
Male (n, %) 17 (81%)
clinical data
Presenting symptoms
  Poor interrupted feeding (n, %) 2 (9.5%)
  Dyspnea (n, %) 8 (38%)
  Accidentally discovered murmur (n, %) 11 (52.5%)Al Marshafawy et al
60  Clinical Medicine Insights: Cardiology 2012:6
(P , 0.001) in all patients regardless the aortic valve 
anatomy. Left ventricular pressure decreased immedi-
ately from 145.4 ± 13.8 mmHg to 103.25 ± 3.6 mmHg 
(P  ,  0.001).  In  the  3  patients  with  associated 
COA,  there  were  a  reduction  in  peak-peak  pres-
sure gradient across COA after balloon angioplasty 
from  58.6  ±  11.9  mmHg  to  14.4  ±  0.54  mmHg 
(P , 0.001).
Furthermore, we detected significant   reduction 
in  maximum  pressure  gradient  across AV  [from 
77.95  ±  5.9  mmHg  to  26.9  ±  2.26  mmHg 
(P , 0.001)] and COA [from 67.33 ± 14.3 mmHg 
to 14.3 ± 0.57 mmHg (P , 0.001)] one day after 
the  procedure  by  CWD  echocardiography.  We 
had two deaths; one patient with bicuspid aortic 
valve was complicated post intervention by severe 
aortic   insufficiency (AI) which was not correct-
able and died with intractable heart failure about 
48 hours after the procedure. The other one was a 
neonate who had severely compromised LV sys-
tolic function (15%) and died in the same day of 
the procedure.
One patient (4.8%) developed bradycardia   during 
BAV which was reversible at the end of the   procedure; 
another  patient  (4.8%)  developed    ventricular 
  fibrillation  during  the  procedure    necessitating 
  cardioversion. One patient (4.8%) (with associated 
aortic coarctation) was complicated immediately after 
intervention with impalpable femoral artery   pulsation 
due to thrombus necessitating   anticoagulation with 
low  molecular  weight  heparin  to  resume  arterial 
  patency (Table 4).
Eight patients (38%) did not develop aortic insuf-
ficiency  (AI),  9  patients  (42.8%)  had  grade  I AI, 
2 patients (9.5%) had grade II AI, 1 patient (4.8%) 
had grade III AI and only one patient (4.8%) had 
grade IV AI and died after the procedure (Table 4). 
The degree of AI was positively correlated to the 
Table 3. early and intermediate term results.
Baseline (n = 21)  
mean ± sD
early outcome (n = 21)  
mean ± sD
Intermediate outcome (n = 19)  
mean ± sD
P1 P2
Hemodynamic variables
Left ventricular pressure  
(mmhg)
145.4 ± 13.8 103.25 ± 3.6 ,0.001*
Peak-to-peak Pg  
(AV) (mmhg)
  66.7  ± 9.8   20.65 ± 2.99 ,0.001*
Peak-to-peak Pg  
(CoA) (mmhg)#
   58  ± 11.9   14.4  ± 0.54 ,0.001*
echocardiographic variables
Maximum pressure  
gradient (AV) (mmhg)
77.95 ± 5.9   26.9  ± 2.26 21.18 ± 7.42 ,0.001* 0.32
Mean pressure gradient  
(AV) (mmhg)
36.88 ± 7.2   9.42  ± 1.9   8.45 ± 5.8 ,0.001* 0.24
Maximum pressure  
gradient CoA) (mmhg)#
67.33 ± 14.3   14.3  ± 0.57   20.1 ± 2.8 ,0.004* 0.135
note: #3 patients had associated CoA. P1: baseline vs. early outcome values, P2: early outcome vs. intermediate outcome.
Abbreviations: AV, aortic valve; CoA, coarctation. 
Table 2. Basal echocardiographic data of the patients.
echocardiographic data
Peak instantaneous pressure gradient  
(AV) [mmhg, mean ± SD]
77.95 ± 5.9
Mean pressure gradient (AV)  
[mmhg, mean ± SD]
36.88 ± 7.2
Valve anatomy
  Tricuspid (n, %) 15 (71.5%)
  Bicuspid (n, %) 6 (28.5%)
FS% (mean ± SD)
  FS% , 28% (n, %) 1 (4.8%)
  FS% $ 28 (n, %) 20 (95.2%)
Aortic insufficiency
  grade 0 (n, %) 17 (81%)
  grade I (n, %) 3 (14.3%)
  grade II (n, %) 1 (4.8%)
  grade III (n, %) 0 (0%)
  grade IV (n, %) 0 (0%)
Associated COA (n, %) 3 (14.3%)
Peak instantaneous pressure gradient  
(CoA) [mmhg, mean ± SD]
67.33 ± 14.3
Abbreviations: FS%, Fractional Shortening %; AV, Aortic Valve; CoA, 
Coarctation aorta.Balloon aortic valvuloplasty in childhood
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  balloon/annulus ratio used (r = 0.72, P , 0.001) but 
not correlated to the valve morphology (r = 0.23, 
P = 0.133). Comparison between patients with tri-
cuspid aortic valve and those with bicuspid AV as 
regard the degree of AI after BAV showed no sig-
nificant difference (P = 0.10). The balloon/annulus 
ratio used was 0.83 ± 0.04 (range from 0.8 to 1). 
All patients, except the two deaths and the patient, 
who required anticoagulation, were discharged home 
within 24 hours after the procedure.
Intermediate-term results
Nineteen patients were followed up post-intervention. 
The duration of follow up ranges from 6–38 months 
(mean ± SD 18.5 ± 11.7 months). The patients were 
followed up clinically and by echocardiography every 
three months for recurrence of symptoms, develop-
ment of AI or increase in its grade, restenosis of the 
aortic  valve  and  myocardial  function.  Concerning 
maximum pressure gradient across the AV measured 
by CWD echocardiography, we found no statistically 
significant difference between values of immediate and 
those of intermediate term results (26.9 ± 2.26 mmHg 
and  21.18  ±  7.42  mmHg  respectively,  P  =  0.32). 
Moreover,  mean  pressure  gradient  across AV  was 
not  differed  significantly  (9.42  ±  1.9  mmHg  and 
8.45 ± 5.8 mmHg respectively, P = 0.24). With fol-
low up of patients who had CoA, peak instantaneous 
pressure gradient across the site of CoA showed no 
significant increase compared to immediate results 
(14.3 ± 0.57 mmHg and 20.1 ± 2.8 mmHg respec-
tively, P = 0.135) (Table 3). The grade of AI did not 
increase in all patients during follow up.
Discussion
Intervention for AVS in pediatrics with trans-catheter 
balloon dilatation and surgical valvotomy have, in the 
past, been associated with high mortality rates.8 Risk 
factors for poor outcome have been attributed to young 
age at presentation,17,18 small left heart dimensions,8,19 
and endocardial fiobroelastosis.20 With improvement 
of catheterization technology,21 the survival rates with 
BAV have improved.22 The effectiveness of BAV in 
pressure reduction of the LV has been reported by 
several authors.23–25
In this study, we found that BAV provided imme-
diate  and  intermediate-term  gradient  reduction  in 
children with congenital AVS. We observed that peak-
to-peak  pressure  gradient  decreased  in  all  patients 
regardless the aortic valve morphology. Many previ-
ous studies had supported these results.23,26,27
Aortic  incompetence  (AI)  has  been  previously 
identified as the main indication for aortic valve sur-
gery after BAV.28 In our study, AI was absent in 38% of 
patients, grade I in 42.8%, grade II in 9.5%, grade III 
in 4.8% and IV in 4.8% of cases. Degree of AI was not 
related to the valve morphology but showed signifi-
cant correlation with the balloon/annulus ratio. Reich 
and  coworkers  showed  that  functionally  bicuspid 
aortic valve morphology is an independent risk fac-
tor for AI after BAV.24 However, in our patients, the 
usage of smaller balloon/annulus ratio could explain 
the significant low incidence of AI. In agreement with 
Knirch et al29 who concluded that aortic valve mor-
phology is not a risk factor for early outcome in BAV 
in children.
The in-hospital mortality was detected in 2 patients 
(9.5%). The low mortality and low acute postopera-
tive complications in our study can be explained by 
small number of neonates, small number of patients 
with reduced myocardial function before intervention 
and again, due to low balloon/annulus ratio; known 
risk factors to increase acute complications.29
One patient died due to intractable heart failure as a 
result of severe (grade IV) AI after BAV despite using 
balloon/annulus  ratio  ,1.  The  most    unpredictable, 
frustrating and probably, the most common complica-
tion of BAV is the creation of significant AI.   Significant 
AI occurs in approximately 10% of all BAV. This num-
ber is comparable to its occurrence following surgical 
aortic valvotomy. It appears that over-sizing of the 
balloon for aortic valve annulus is one predictor for 
Table 4. Procedure details and complications.
procedure details
Balloon/annulus ratio (mean ± SD)  
(range)
0.83 ± 0.04 
(0.8–1)
Femoral artery access (n, %) 20 (95.2%)
Carotid artery access (n, %) 1 (4.8%)
Median number of balloon inflations  
(median, range)
2 (1–5)
complications
Bradycardia (temporary) (n, %) 1 (4.8%)
Ventricular fibrillation (n, %) 1 (4.8%)
early deaths (,30 days) (n, %) 2 (9.5%)
Late deaths (.30 days) (n, %) 0 (0%)
Aortic insufficiency grade IV (n, %) 1 (4.8%)
Femoral occlusion (n, %) 1 (4.8%)Al Marshafawy et al
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the creation of AI, however AI is created even when 
using a precisely measured balloon/annulus ratio ,1. 
The wire and then the balloon passage through a valve 
leaflet rather than through the commissures/orifice of 
the valve results in significant AI.30
The  other  patient  was  a  neonate  who  had  pre-
  intervention affected LV myocardial systolic function 
(FS 15%). He died within 24 hours after the procedure 
by heart failure. Neonate aortic stenosis is a fatal disease 
that associated with myocardial dysfunction due to sub-
endocardial  ischemia  or  endocardial    fibroelastosis.31 
Myocardial dysfunction is one of the main variables in 
the prognosis of patients with aortic stenosis in neonate 
period. Myocardial dysfunction due to abnormal myo-
cardial perfusion disables the LV preventing it from 
maintaining normal cardiac output.32
The femoral approach is used routinely in most 
centers33 and it was used in most of our patients. One 
patient  (4.8%)  was  complicated  by  femoral  artery 
occlusion post-operatively and was managed by low 
molecular weight heparin infusion with regained arte-
rial patency.
Carotid  artery  approach  was  performed  in  one 
patient. This approached was considered when there 
are problems in femoral or umbilical catheterization 
approach.34 Many previous studies had demonstrated 
the use of carotid artery approach to BAV.35,36
Adenosine is a powerful drug that creates arterial 
hypotension and leads to transient cardiac stand-still 
after  bolus  injection.37  It  was  used  in  our  patients 
to slow heart rate and hence stabilize the balloon. 
  Balloon stability during the BAV procedure is crucial 
for a successful outcome and is likely to reduce com-
plications. RV pacing was not used in our patients as 
it is used in older age groups and needs an additional 
venous access.38
In our study, 3 patients (14.3%) had associated dis-
crete coarctation and underwent balloon angioplasty 
in the same catheterization setting. Coexistence of 
AVS and CoA is relatively uncommon, but the exact 
prevalence  is  unknown.39–41  With  balloon  angio-
plasty, we found a significant reduction in peak-to-
peak gradient across the coarcted segment. Balloon 
angioplasty of native CoA gained more acceptance 
in children.42 Tokel and his colleagues43 studied the 
sequential balloon dilatation for combined AVS and 
CoA in children and found results to ours.
None  of  our  patients  was  complicated  by 
  aneurysm at the coarcted segment. On follow up, no 
  recurrence of pressure gradient across CoA segment 
in these patients. Similar findings were observed by 
many authors.44,45
conclusion
Balloon valvuloplasty of aortic valve stenosis signifi-
cantly reduces gradient with low morbidity and mor-
tality in children.
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